Filter
261
Filtered Results: 261
Text search:
Model
Formulary
Featured
Recommendations
33
New Publications
64
Language
Document type
No document type
109
Guidelines
74
Studies & Reports
37
Manuals
19
Training Material
11
Strategic & Response Plan
5
Situation Updates
4
Resource Platforms
1
Fact sheets
1
Countries / Regions
South Africa
12
Kenya
10
Liberia
9
Latin America and the Carribbean
8
Global
8
India
7
Nigeria
6
Western and Central Europe
6
Africa
6
Ethiopia
5
Uganda
4
Zambia
3
Syria
3
Tanzania
3
Venezuela
3
Ghana
2
Philippines
2
Botswana
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Jamaica
2
Sierra Leone
1
Cameroon
1
Haiti
1
Jordan
1
Thailand
1
Indonesia
1
Mozambique
1
Argentina
1
Namibia
1
Colombia
1
Ecuador
1
El Salvador
1
Yemen
1
Middle East and North Africa
1
Western Pacific Region
1
Asia
1
Eastern Europe
1
Qatar
1
Authors & Publishers
Publication Years
Category
Countries
76
Clinical Guidelines
40
Women & Child Health
18
Public Health
16
Key Resources
7
Capacity Building
5
Pharmacy & Technologies
4
Toolboxes
Pharmacy
40
AMR
39
Mental Health
24
HIV
17
NCDs
10
TB
9
Conflict
7
COVID-19
6
Rapid Response
5
Planetary Health
4
Natural Hazards
3
Caregiver
3
Refugee
2
Specific Hazards
2
Disability
1
Global Health Education
1
NTDs
1
WHO Model Formulary for Children
recommended
WHO Model Formulary for children based on the Second Model List of Essential Medicines for Children 2009.
In 2007, the World Health Assembly pass...
WHO Model Formulary
recommended
For each medicine the Formulary provides information on use, dosage, adverse effects, contraindications and warnings, supplemented by guidance on selecting the right medicine for a range of conditions
All WHO essential medicines are covered in Wikipedia: https://en.wikipedia.org/wiki/WHO_Model_List_of_Essential_Medicines, and items are translated in several languages. Increasing the amount, quality and languages of information on essential medici...
Countries with free access to BNF and BNF for Children on MedicinesComplete via HINARI
Registered users of the BNF website are allowed free access to the core content of the latest edition of the BNF and BNF for Children on the MedicinesComplete website if they reside in England, Scotland, Wales, N...
This interagency report provides recommendations for assuring quality of medicines during key activities of country-level procurement agencies, namely prequalification of pharmaceutical products and manufacturers; purchase of pharmaceutical products; storage of pharmaceutical products; and distribut...
Dermatological Preparations For The Tropics
recommended
A formulary of dermatological preparations and background information on therapeutic choices, production and dispensing. 2nd edition
Formularies are lists of antibiotics that are suggested for certain healthcare settings. In developing a recommended formulary, countries should consider the needs of patients and facilities where t...
Using the WHO model list of essential medicines to update a national essential medicines list
Since 1977, WHO has been working with countries to design the package of essential medicines as an integral component of treatment within the continuum of...
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo...
The National Action Plan (NAP) has been developed based on the model recommended in the global Action Plan. Local data on on-going interventions were collected from technical informants in the various areas of work. These were analysed using the pol...
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential Medicines (EML) and the <... List of Essential Medicine for Children (EMLc).
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and formulation on the Model Lists of Essential Medicines. The Committee evaluated the scientific evidence for comparative effectiveness, safety and cost-effectiveness of the medicines in question. The Committee also considered a review of the therapeutic alternatives for medicines on the Model Lists, and update to the AWaRe classification of antibiotics, and reviews and reports relevant to the selection and use of essential medicines.
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or ...ies for these or other herbal medicines; and
• facilitate information exchange among Member States.
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or ...ies for these or other herbal medicines; and
• facilitate information exchange among Member States.
This report aims to estimate the economic cost of providing regular access to healthcare for migrants in an irregular situation, compared with the cost of providing treatment in emergency cases only. Two specific medical conditions – hypertension and prenatal care – were selected as examples, an...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or ...ies for these or other herbal medicines; and
• facilitate information exchange among Member States.
Antimicrobial resistance (AMR) has emerged as a major public health problem all over the world. Infections caused by resistant microbes fail to respond to treatment, resulting in prolonged illness and greater risk of death. This document focuses on the mechanism to develop a practically applicable h...
